Pralidoxime chloride injection

Product Details
img
Name Of Product(Genric Name) :

Pralidoxime chloride injection 500mg

Dosage :

1000MG

Product Description :

PRALIDOXIME CHLORIDE INJECTION

Sterile Powder for Solution for Intravenous or Intramuscular Administration

  1. COMPOSITION

Each vial contains:

Pralidoxime Chloride ...............500mg

Excipients: As applicable.

  1. PHARMACEUTICAL FORM

Sterile, white to off-white powder for solution for intravenous or intramuscular administration.

  1. THERAPEUTIC CLASS

Cholinesterase Reactivator / Oxime Antidote

  1. INDICATIONS

Pralidoxime Chloride Injection is indicated as an antidote in the treatment of poisoning due to organophosphorus compounds.

It may be used in:

• Organophosphate insecticide poisoning
• Organophosphate nerve-agent poisoning
• Poisoning associated with inhibition of cholinesterase activity

Pralidoxime is generally used in conjunction with appropriate supportive treatment and atropine when clinically indicated.

  1. CONTRAINDICATIONS

Pralidoxime Chloride is contraindicated in patients with known hypersensitivity to pralidoxime chloride or any component of the formulation.

Appropriate clinical assessment should be undertaken before administration.

  1. DRUG INTERACTIONS

Particular consideration may be required with concomitant use of:

• Atropine
• Other antidotes used in organophosphate poisoning
• Medicines affecting neuromuscular transmission

The treating physician should review all concomitant medications before administration.

  1. ADMINISTRATION

Pralidoxime Chloride Injection may be administered by intravenous or intramuscular route according to the approved product information.

The contents of the vial should be reconstituted with a suitable compatible diluent under appropriate aseptic conditions.

The reconstituted solution should be administered by a qualified healthcare professional according to the approved product information and institutional protocol.

  1. STORAGE

Store according to the storage conditions stated on the approved product label.

Protect from excessive heat, moisture and light.

After reconstitution, use within the period specified in the approved product information.

Do not use if the reconstituted solution shows visible particles, precipitation or unexpected discoloration.

Dry Powder Injection